Latest North America Generics News & Updates

Mumbai, Jan 21 (IANS) Dr Reddy’s Laboratories on Wednesday reported a 14 per cent decline in its consolidated net profit for the December quarter (Q3) of FY26.The drugmaker said its consolidated net profit fell 14 per cent year-on-year (YoY) to Rs 1,209.8 crore in Q3 FY26, compared with Rs 1,413.3 crore in the same quarter last financial year, according to its stock exchange filing.Revenue from operations during the quarter rose 4.4 per cent to Rs 8,726.8 crore, up from Rs 8,358.6 crore in the y…